The Analysis And Research Of Merger And Acquisition Of Pharmaceutical Industry In China

Thanks to China's Reform and Opening-up, the pharmaceutical industry grew faster than the growth of GDP. However, there are some issues that will affect the increase of pharmaceutical enterprises, the supply of medicine, and the people's medical quality. Accordingly with these issues, a large number of mergers and acquisitions (M&As) took place in order that those problems could be solved.It is very important and valuable to conduct analysis and research on M&As of pharmaceutical industry.This essay made an analysis of the background and effects of M&As in the Chinese pharmaceutical industry. It is clear that M&As can optimize the pharmaceutical industry resources and improve the competitive forces of the companies. Then, the author got to a conclusion that the M&As of the pharmaceutical industry in China is imperative.After dealing with abundant cases and data resources, this research focused on the behavior and features of the M&As of the listed pharmaceutical enterprises. After the analysis of several examples, the author put forward the reasons of successful and failed M&As in Chinese pharmaceutical industry.Key success indications of the M&As in the pharmaceutical industry are discussed in these aspects, such as strategy, object analysis, valuation, target selection, method of payment and so on. Internal and external risks are researched and should be cared about.Finally, the trends of the M&As in Chinese pharmaceutical industry are predicted.